The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
A System of Classifying Microvascular Invasion to Predict Outcome After Resection in Patients With Hepatocellular Carcinoma
Open accessAbstract
Background & Aims Hepatocellular carcinoma (HCC) recurs in approximately 70% of cases after resection. Vascular invasion by tumor cells can be classified as gross or microscopic (mVI) and is a risk factor for recurrence. We examined a large cohort of patients with HCC that were treated by resection to identify features of microvascular invasion that correlated with recurrence and survival. Methods We reviewed the records of all HCC resections performed at the Mount Sinai School of Medicine between January 1990 and March 2006 to identify those with mVI, established by histological analysis. The numbers and sizes of vessels invaded, invasion of a vessel with a muscular wall, distance from the tumor, and satellite nodules were recorded. Results Of the 384 patients that underwent resection for HCC, 131 (34.1%) met the entry criteria. The median follow-up period was 28.9 mo. There were 68 recurrences and 54 deaths. In multivariate analysis, invasion of a vessel with a muscular wall predicted recurrence (hazard ratio 1.8, P=0.02); invasion of a vessel with a muscular wall (hazard ratio=2.2, P=0.018) and invasion of a vessel that was more than 1 cm from the tumor (hazard ratio=2.1, P=0.015) predicted survival. A risk score that assigned point for the presence of each variable was correlated with recurrence (p=0.028) and survival (p<0.0001). Conclusion A novel classification system that includes invasion of a vessel with a muscular wall and invasion of a vessel that is more than 1 cm from the tumor can accurately predict risk of recurrence and survival of patients with mVI after HCC resection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Self-citationSorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Llovet, J. M., Fuster, J., & Bruix, J. (1999) · Hepatology · doi:10.1002/hep.510300629 · Cited by 1,708
Self-citationImamura, H., Matsuyama, Y., Tanaka, E., Ohkubo, T., Hasegawa, K., Miyagawa, S., Sugawara, Y., Minagawa, M., Takayama, T., Kawasaki, S., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00360-4 · Cited by 1,589
Ishizawa, T., Hasegawa, K., Aoki, T., Takahashi, M., Inoue, Y., Sano, K., Imamura, H., Sugawara, Y., Kokudo, N., & Makuuchi, M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.091 · Cited by 754
Simplified Staging for Hepatocellular Carcinoma
Vauthey, J. N., Lauwers, G. Y., Esnaola, N. F., Do, K.-A., Belghiti, J., Mirza, N., Curley, S. A., Ellis, L. M., Regimbeau, J.-M., Rashid, A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1527 · Cited by 700
Intrahepatic Recurrence After Resection of Hepatocellular Carcinoma Complicating Cirrhosis
BELGHITI, J., PANIS, Y., FAROES, O., BENHAMOU, J. P., & FEKETE, F. (1991) · Annals of Surgery · doi:10.1097/00000658-199108000-00004 · Cited by 562
Ikai, I., Arii, S., Kojiro, M., Ichida, T., Makuuchi, M., Matsuyama, Y., Nakanuma, Y., Okita, K., Omata, M., Takayasu, K., et al. (2004) · Cancer · doi:10.1002/cncr.20426 · Cited by 451
Patterns of Recurrence After Initial Treatment in Patients With Small Hepatocellular Carcinoma
Kumada, T., Nakano, S., Takeda, I., Sugiyama, K., Osada, T., Kiriyama, S., Sone, Y., Toyoda, H., Shimada, S., Takahashi, M., et al. (1997) · Hepatology · doi:10.1002/hep.510250116 · Cited by 378
Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma
Zhou, X.-D., Tang, Z.-Y., Yang, B.-H., Lin, Z.-Y., Ma, Z.-C., Ye, S.-L., Wu, Z.-Q., Fan, J., Qin, L.-X., & Zheng, B.-H. (2001) · Cancer · doi:10.1002/1097-0142(20010415)91:8<1479::aid-cncr1155>3.0.co;2-0 · Cited by 302
Sala, M., Fuster, J., Llovet, J. M., Navasa, M., Solé, M., Varela, M., Pons, F., Rimola, A., García-Valdecasas, J. C., Brú, C., et al. (2004) · Liver Transplantation · doi:10.1002/lt.20202 · Cited by 297
Self-citationRisk factors for intrahepatic recurrence in human small hepatocellular carcinoma
Adachi, E., Maeda, T., Matsumata, T., Shirabe, K., Kinukawa, N., Sugimachi, K., & Tsuneyoshi, M. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90450-6 · Cited by 272
Predictive factors for postoperative recurrence of hepatocellular carcinoma
Okada, S., Shimada, K., Yamamoto, J., Takayama, T., Kosuge, T., Yamasaki, S., Sakamoto, M., & Hirohashi, S. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90419-7 · Cited by 268
Preoperative Predictors of Survival After Resection of Small Hepatocellular Carcinomas
Wayne, J. D., Lauwers, G. Y., Ikai, I., Doherty, D. A., Belghiti, J., Yamaoka, Y., Regimbeau, J.-M., Nagorney, D. M., Do, K.-A., Ellis, L. M., et al. (2002) · Annals of Surgery · doi:10.1097/00000658-200205000-00015 · Cited by 189
Poon, R. T. P., & Fan, S.-T. (2003) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(02)00086-8 · Cited by 98
Cited by
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
“A more accurate observation of microvascular invasion has led to the identification of invasion of a muscular wall vessel or of more than 1 cm beyond the tumor edge as the 2 worst risk factors for prognosis [157].”
BackgroundEASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
(2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.021 · Cited by 1,096
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., D’Angelica, M. I., Abbott, D. E., Anaya, D. A., Anders, R., Are, C., Bachini, M., Borad, M., Brown, D., Burgoyne, A., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0022 · Cited by 1,003
Rodríguez-Perálvarez, M., Luong, T. V., Andreana, L., Meyer, T., Dhillon, A. P., & Burroughs, A. K. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2513-1 · Cited by 657
de Lope, C. R., Tremosini, S., Forner, A., Reig, M., & Bruix, J. (2012) · Journal of Hepatology · doi:10.1016/s0168-8278(12)60009-9 · Cited by 610
Metadata
- Authors
- Roayaie, S., Blume, I. N., Thung, S. N., Guido, M., Fiel, M., Hiotis, S., Labow, D. M., Llovet, J. M., & Schwartz, M. E.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 137
- Issue
- 3
- Pages
- 850-855
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2056207351
- Cited by
- 660
- References
- 15
- FWCI
- 8.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.